215 related articles for article (PubMed ID: 6839194)
1. Structure-activity relationships of various bisphosphonates.
Shinoda H; Adamek G; Felix R; Fleisch H; Schenk R; Hagan P
Calcif Tissue Int; 1983; 35(1):87-99. PubMed ID: 6839194
[TBL] [Abstract][Full Text] [Related]
2. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
Lerner UH; Larsson A
Bone; 1987; 8(3):179-89. PubMed ID: 2955802
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
Flanagan AM; Chambers TJ
Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
[TBL] [Abstract][Full Text] [Related]
4. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.
Schenk R; Eggli P; Fleisch H; Rosini S
Calcif Tissue Int; 1986 Jun; 38(6):342-9. PubMed ID: 3089557
[TBL] [Abstract][Full Text] [Related]
5. Effect of halogenmethylenebisphosphonates on bone cells in culture and on bone resorption in vivo.
Felix R; Fleisch H; Schenk R
Experientia; 1986 Mar; 42(3):302-4. PubMed ID: 3956686
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse.
Marie PJ; Hott M; Garba MT
Bone; 1985; 6(3):193-200. PubMed ID: 4027097
[TBL] [Abstract][Full Text] [Related]
7. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.
Reitsma PH; Teitelbaum SL; Bijvoet OL; Kahn AJ
J Clin Invest; 1982 Nov; 70(5):927-33. PubMed ID: 7130396
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages.
Stevenson PH; Stevenson JR
Calcif Tissue Int; 1986 Apr; 38(4):227-33. PubMed ID: 3085901
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
Marie PJ; Hott M; Garba MT
Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats.
Reitsma PH; Bijvoet OL; Verlinden-Ooms H; van der Wee-Pals LJ
Calcif Tissue Int; 1980; 32(2):145-57. PubMed ID: 6773632
[TBL] [Abstract][Full Text] [Related]
11. Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.
Flanagan AM; Chambers TJ
Bone Miner; 1989 Apr; 6(1):33-43. PubMed ID: 2526673
[TBL] [Abstract][Full Text] [Related]
12. Differential response of bone cells isolated by sequential digestion to dichloromethylenebisphonate in culture.
Guenther HL; Gallagher JA; Fleisch H
Calcif Tissue Int; 1984 Sep; 36(5):568-75. PubMed ID: 6098352
[TBL] [Abstract][Full Text] [Related]
13. The bisphosphonates HEBP and AHPrBP but not AHBP inhibit mineral mobilization and lysosomal enzyme release from mouse calvarial bones in tissue culture.
Lerner U; Larsson A
Experientia; 1984 Sep; 40(9):965-7. PubMed ID: 6468624
[TBL] [Abstract][Full Text] [Related]
14. Effect of bisphosphonates on prostaglandin synthesis by rat bone cells and mouse calvaria in culture.
Ohya K; Yamada S; Felix R; Fleisch H
Clin Sci (Lond); 1985 Oct; 69(4):403-11. PubMed ID: 3862498
[TBL] [Abstract][Full Text] [Related]
15. The effects of bisphosphonates on the resorption cycle of isolated osteoclasts.
Selander K; Lehenkari P; Väänänen HK
Calcif Tissue Int; 1994 Nov; 55(5):368-75. PubMed ID: 7532540
[TBL] [Abstract][Full Text] [Related]
16. Bone resorption in orthotopic and heterotopic bone of dichloromethylene bisphosphonate-treated rats.
Nilsson OS; Bauer HC; Brosjö O; Törnkvist H
J Orthop Res; 1990 Mar; 8(2):213-9. PubMed ID: 2137534
[TBL] [Abstract][Full Text] [Related]
17. The anabolic action of 17 beta-estradiol (E2) on rat trabecular bone is suppressed by (3-amino-1-hydroxypropylidene)-1-bisphosphonate (AHPrBP).
Abe T; Chow JW; Lean JM; Chambers TJ
Bone Miner; 1992 Oct; 19(1):21-9. PubMed ID: 1422303
[TBL] [Abstract][Full Text] [Related]
18. Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1.
Igarashi K; Hirafuji M; Adachi H; Shinoda H; Mitani H
Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):121-5. PubMed ID: 9051721
[TBL] [Abstract][Full Text] [Related]
19. Effects of bisphosphonates on the incorporation of calcium-45 and 3H-proline in orthotopic and in demineralized matrix-induced bone in rats.
Bauer HC; Törnkvist H; Nilsson OS
Bone; 1986; 7(2):129-35. PubMed ID: 2941039
[TBL] [Abstract][Full Text] [Related]
20. Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
Reitsma PH; Bijvoet OL; Potokar M; van der Wee-Pals LJ; van Wijk-van Lennep MM
Calcif Tissue Int; 1983 May; 35(3):357-61. PubMed ID: 6871766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
